Sunbird Bio

Cambridge, MA · Founded 2020 · Privately Held (backing)

Developer of a diagnostics platform designed to provide fast and accurate results in molecular diagnostics. Sunbird Bio is based in Cambridge, MA and was founded in 2020. Its last reported valuation was $16 million in Nov 2022. It has raised $27.3 million across 1 recorded round; the latest was a $23.2 million early-stage round in Apr 2023.

Last reported valuation
$16.0M
Oct 2026
Priced at
—
Total raised
$27.3M
Last round
Early Stage VC
Apr 2023
What is Sunbird Bio worth?
$16.0Mlast reported valuation · Oct 2026

Sunbird Bio's last reported valuation, Nov 2022. Nothing priced has surfaced since.

Private Market View
More of Sunbird Bio with a free Private Market View account
  • ·The complete investor list: 11 names
  • ·Watch Sunbird Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 38 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free Private Market View account.Unlock the axis

Membership and data by Private Market View

Sunbird Bio funding history

1 rounds
DateRoundRaisedPost-money
Apr 2023Early Stage VC$23.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Sunbird Bio valuation

Sunbird Bio's last reported valuation was $16 million in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Sunbird Bio raised?

Sunbird Bio has raised $27.3 million across 1 recorded round since 2023. The largest was a $23.2 million early-stage round in Apr 2023.

Sunbird Bio has filed 1 Form D with the SEC, most recently in May 2023 ($23.2 million sold to 10 investors).

How Sunbird Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Sunbird Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Sunbird Bio

What is Sunbird Bio worth?
Sunbird Bio is valued at $16.0M as of Oct 2026. Sunbird Bio's last reported valuation, Nov 2022. Nothing priced has surfaced since.
How much has Sunbird Bio raised?
Sunbird Bio has raised $27.3M in total funding across 1 recorded rounds.
When did Sunbird Bio last raise?
Sunbird Bio last raised in Apr 2023 (Early Stage VC), raising $23.2M.